The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR

NACompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

January 20, 2021

Study Completion Date

February 20, 2021

Conditions
Proliferative Diabetic Retinopathy
Interventions
PROCEDURE

IVA injection before vitrectomy

Patients in IVA group received an IVA (0.5 mg/0.05 ml) injection before surgery (1 to 5 days before surgery)

Trial Locations (1)

100044

People's Hospital of Peking University, Beijing

Sponsors
All Listed Sponsors
collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

The Affiliated Hospital of Xuzhou Medical University

OTHER

collaborator

The First Affiliated Hospital of Nanchang University

OTHER

collaborator

Nanjing Medical University

OTHER

collaborator

Xiamen University

OTHER

lead

Peking University People's Hospital

OTHER

NCT05478967 - The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR | Biotech Hunter | Biotech Hunter